Por favor, use este identificador para citar o enlazar este ítem: 10.1002/mds.27958

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorAlmela, Pilar-
dc.contributor.authorCuenca Bermejo, Lorena-
dc.contributor.authorYuste, José E.-
dc.contributor.authorEstrada, Cristina-
dc.contributor.authorPablos, Vicente de-
dc.contributor.authorBautista Hernández, Víctor-
dc.contributor.authorFernández Villalba, Emiliano-
dc.contributor.authorLaorden, María Luisa-
dc.contributor.authorHerrero Ezquerro, María Trinidad-
dc.date.accessioned2024-02-09T12:00:14Z-
dc.date.available2024-02-09T12:00:14Z-
dc.date.issued2019-11-
dc.identifier.citationMovement Disorders (2019)es
dc.identifier.issn0885-3185-
dc.identifier.issn1531-8257-
dc.identifier.urihttp://hdl.handle.net/10201/139115-
dc.description©2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Published, version of a Published Work that appeared in final form in Movement Disorders. To access the final edited and published work see https://doi.org/10.1002/mds.27958es
dc.description.abstractABSTRACT: Background: Autonomic dysfunction is a well-known dominant symptom in the advanced stages of Parkinson’s disease. However, the role of cardiac sympathetic nerves still needs to be elucidated. Objectives: To evaluate cardiac sympathetic response in Parkinsonian and dyskinetic monkeys. Methods: Adult male monkeys were divided into 1 of the following 3 groups: controls, 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine–treated monkeys, and 1-methyl4-phenyl-1,2,3,6-tetrahydropyridine+levodopa–treated animals. Noradrenaline, its metabolite normetanephrine, and phospho-Heat shock proten 27 (p-Hsp27) at erine 82 levels were analyzed in the left and right ventricles of the heart. Tyrosine hydroxylase immunohistochemistry was performed in the ventral mesencephalon. Results: The results were the following: (1) 1-methyl4-phenyl-1,2,3,6-tetrahydropyridine intoxication significantly increased normetanephrine levels and decreased noradrenaline turnover in the right ventricle without changes in the left ventricle; however, (2) levodopa treatment decreased noradrenaline levels and enhanced the normetanephrine/noradrenaline ratio in parallel with a very significant increase of Hsp27 activity in both ventricles. Conclusions: Levodopa treatment could induce protective cardiac effects through the increased Hsp27 activity. © 2019 International Parkinson and Movement Disorder Societyes
dc.formatapplication/pdfes
dc.format.extent6es
dc.languageenges
dc.publisherWiley Online Libraryes
dc.relationFunding agencies: This work was supported by grants from the Spanish Ministry of Science (SAF 2007-62262; SAF/FEDER2013-49076-P; FIS PI1002827) and Fundación Séneca (FS/15329/PI/10).es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHsp27es
dc.subjectL-dopaes
dc.subjectNA turnoveres
dc.subjectParkinson’s diseasees
dc.subjectTHes
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicinaes
dc.titleCardiac Noradrenaline Turnover and Heat Shock Protein 27 Phosphorylation in Dyskinetic Monkeys.es
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1002/mds.27958-
dc.contributor.departmentAnatomía Humana y Psicobiología-
Aparece en las colecciones:Artículos

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
2019 Cardiac Noradrenaline Turnover and Heat Shock Protein 27 Phosphorylation in Dyskinetic Monkeys.pdf849,93 kBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons